Tag: Pfizer

Pfizer Inc. is an American global pharmaceutical corporation headquartered in New York City, with its research headquarters in Groton, Connecticut. It is among the world’s largest pharmaceutical companies. Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, diabetology/endocrinology, and neurology.

Pfizer and Catalia Will Use AI Robot to Help Patients in Real Time

Pfizer and Catalia Health have launched a year-long pilot scheme exploring how patients engage with cute robot companions that use artificial intelligence (AI) to check on symptom management and help ...

FDA Accepted for Review sNDA for XTANDI®

Astellas Pharma Inc. and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for review the filing of a supplemental New Drug Application (sNDA) for XTANDI® (enzalutami...

Pfizer Invests Billions in Gene Therapy Manufacturing Facility

gene-engineering
Pfizer announced an additional half billion dollar investment for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina. This facility is anticipated ...

Pfizer Recalls Migraine Drug

pfizer
Pfizer has volountarily recalled the migraine medication Relpax because of the potential presence of Genus Pseudomonas and Burkholderia. Two lots of the migraine medication, Relpax (eletriptan hydr...

Pfizer Announced Negative Phase 3 Results for Rivipansel

pfizer
Pfizer announced that the Phase 3 Rivipansel (GMI1070): Evaluating Safety, Efficacy and Time to Discharge (RESET) pivotal study did not meet its primary or key secondary efficacy endpoints. The obj...

GSK & Pfizer Form New Consumer Healthcare Joint Venture

GlaxoSmithKline announced that it has completed its transaction with Pfizer to combine their consumer healthcare businesses into a world-leading Joint Venture. The Joint Venture...

Pfizer Announced Successful Completion of Array BioPharma Acquisition

Pfizer Inc. announced the successful completion of its acquisition of Array BioPharma Inc., advancing breakthrough science for the discovery, development and commercialization of targeted small molecu...

Mylan and Pfizer Agreed to Create New Global Pharmaceutical Company

mylan
Mylan N.V. and Pfizer Inc. announced a definitive agreement to combine Mylan with Upjohn, Pfizer’s off-patent branded and generic established medicines business, creating a new global pharmaceutical c...

FDA Approved RUXIENCE™ for the Treatment of Patients with non-Hodgkin’s Lymphoma

pfizer
Pfizer Inc. announced the United States (U.S.) Food and Drug Administration (FDA) has approved RUXIENCE™ (rituximab-pvvr), a biosimilar to Rituxan® (rituximab), for the treatment of adult patients wit...

Bavencio, Inlyta Combo Granted Early Access to Medicines status by MHRA

Merck and Pfizer have announced that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has issued an Early Access to Medicines Scheme (EAMS) positive scientific opinion for Bavencio (a...

ViiV Healthcare Launch Study for First-Ever Long-Acting Injectable Therapy for HIV

viiv healthcare
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced the start of the CUSTOMIZE trial (Cabotegravir plus Ril...

Pfizer Announced Updated Results from Study Evaluating SB-525 Gene Therapy for Hemophilia A

Sangamo Therapeutics, Inc., a genomic medicine company, and Pfizer, Inc. announced updated results from the Phase 1/2 Alta study evaluating investigational SB-525 gene therapy for severe hemophilia A....

Pfizer Completed Acquisition of Biotechnology Company Therachon Holding AG

Pfizer Inc. announced the successful completion of its acquisition of the privately held clinical-stage biotechnology company Therachon Holding AG. Under the terms of the transaction, Pfizer acquired ...

Pfizer Received FDA Approval for Avastin® Biosimilar

Pfizer Inc. today announced the United States (U.S.) Food and Drug Administration (FDA) has approved ZIRABEV™ (bevacizumab-bvzr), a biosimilar to Avastin® (bevacizumab), for the treatment of five type...

Scott Gottlieb Joins Pfizer’s Board of Directors

Pfizer Inc. announced the election of Dr. Scott Gottlieb to its Board of Directors, effective immediately. Dr. Gottlieb, age 47, was also appointed to the Regulatory and Compliance Committee and the S...

Pfizer UK Recalled Docetaxel Injection 160mg and Docetaxel Injection 20mg

Pfizer
Pfizer UK Limited is recalling batches as routine stability testing has identified that levels of a known impurity, 10-oxo-docetaxel, may exceed the acceptable level at end of shelf-life. CLDA Number...